Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Vision Transformer–based ultrasound AI to detect placenta accreta spectrum

Official title: Diagnostic Trial of Vision Transformer-Based End-to-End Ultrasound Artificial Intelligence Model for Assisting in the Diagnosis of Placenta Accreta Spectrum Disorders: An Investigator-Initiated Prospective Clinical Study

Run by The Third Affiliated Hospital of Guangzhou Medical University · NCT07643090 · Data updated 2026-11-12

A AI tool uses ultrasound video inputs to help see if the placenta is abnormally attached during pregnancy in women at risk.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment561 (estimated)
SponsorThe Third Affiliated Hospital of Guangzhou Medical University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedSeptember 1, 2027
Study endsDecember 31, 2027
Registry record updatedJune 11, 2026
Trial IDNCT07643090 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women aged 18 to 45 with gestational age 24 to 34 weeks, including those with a history of placenta previa or an anterior placenta.

Probably not a fit

Individuals without PAS risk factors or with ultrasound findings clearly indicating normal placentation may not benefit from this diagnostic tool.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study develops an end-to-end Vision Transformer–based AI system to analyze standardized ultrasound video sequences for prenatal PAS detection. The model is trained with postpartum confirmation data and aims to improve consistency and speed of interpretation. The study focuses on translating dynamic ultrasound into reliable diagnostic support for PAS to aid clinical decision-making.

Why it matters

Potential benefit: If successful, the AI system could improve prenatal accuracy and efficiency in diagnosing placenta accreta spectrum, potentially reducing maternal and neonatal complications through earlier, more consistent detection.

How similar studies have gone: Prior studies have shown promise for AI in ultrasound-based prenatal diagnosis, but this specific Vision Transformer–based end-to-end approach for PAS is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Pregnant women aged between 18 and 45 years;
2. Gestational age between 24 and 34 weeks;
3. Pregnant women with a history of placenta previa;
4. Pregnant women with an anterior placenta;
5. Willingness to participate in the study and provision of written informed consent.

Exclusion criteria:

1. Failure to provide written informed consent;
2. Presence of severe complications that precluded continuation of pregnancy;
3. Inability to comply with study procedures for other reasons.

Where it's running

  • The Third Affiliated Hospital, Guangzhou Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.